Grace Halsey

Thirty-day hospital readmission was found to be higher among cardiovascular patients who believed readmission was highly likely vs those who did not believe so.

A majority of primary care clinicians report their patients worry about COVID-19 vaccine side effects and the speed of vaccine development. Most do plan to be vaccinated themselves.

Treating COVID-19 patients under the most challenging physical and emotional conditions has led to a sense of moral injury for many providers, according to Dr Michael Myers.

Johnson & Johnson single-dose COVID-19 vaccine candidate induces durable immune response in participants aged 18 to 55 years; results support further development.

Sotagliflozin reduced CV death and hospitalization for HF in patients with T2D and acute symptomatic HF when given during or immediately after hospitalization.

What are the implications of the global emergence of SARS-CoV-2 variants in terms of disease severity and vaccine and treatment efficacy?

Recommendations address the role of clinicians as vaccinators and stress as essential communication and collaboration with patients' primary care team.

A psychiatrist who exclusively treats health care providers describes his work during the pandemic with clinicians who are treating COVID-19 patients.

The most popular features in preventive cardiology this year were interviews with thought leaders on management of diabetes, hypertension, and hypercholesterolemia.

Interviews with obesity experts, short tests of clinical and guideline knowledge, and news briefs topped the popular content on obesity on Patient Care in 2020.

Biomarkers of nonalcoholic fatty liver disease saw clinically meaningful improvement in a dose-response relationship with weight loss.

The 2 FDA-approved COVID-19 vaccines are similarly effective but also very different in a number of ways that will affect distribution.

An FDA panel voted to recommend the expanded use of sacubitril/valsartan for patients with heart failure with preserved ejection fraction.

Results of a new study suggest a simple clinical approach to assessing individuals at high risk of CHD who would benefit from targeted intervention.

A new Kaiser Family Foundation survey project found 85% of respondents trust their regular healthcare provider for information COVID-19 vaccination. PCPs, read more.

The rapid antigen test for the detection of active COVID-19 in those with and without symptoms produces results within 20 minutes and will retail for about $30.

Among patients with obesity who contracted COVID-19, those with a history of bariatric surgery had significantly decreased odds of hospitalization, a new study finds.

Vaccination against COVID-19 for US healthcare personnel began on December 14, 2020; the same day, CDC hosted a webinar on how to ensure HCP health and safety during this period.

Early COVID-19 vaccine demand will far exceed supply and so states have been refining distribution plans for months. Here is a topline review of what to expect.

Patients with chronic kidney disease have had no treatment options to slow the certain progression to renal failure. Enter SGLT2 inhibitors. A key clinical trial investigator explains.

A high-dose influenza vaccine was no more effective than the standard-dose vaccine at reducing the risk of severe outcomes among patients with heart disease, NIH study finds.

The CDC reduced the length of quarantine required for persons exposed to someone infected with SARS-CoV-2 from 14 days to 10 or to 7 with a negative test.

Primary care clinicians should be the first to prescribe SGLT2 inhibitors for many reasons, as explained by Prof Jonathan McMurray in this Patient Care interview.

DAPA-CKD investigator Professor John McMurray details the trial and renal and cardiovascular outcomes for Patient Care Online.

The expanded indication for baloxavir marboxil is positive news as the surge in US COVID-19 cases converges with the arrival of flu season.

The AstraZeneca/Oxford vaccine candidate showed 90% efficacy in one dosing regimen; 62% in a second; and an average efficacy rate of 70%.

Once-weekly semaglutide 2.0 mg vs 1.0 mg led to statistically significant, superior reductions in A1c and weight in type 2 diabetes patients not at goal, study finds.

Increasing baseline FeNo levels were associated with reduced exacerbation and greater lung function improvement in dupilumab-vs-placebo-treated patients.

COVID-19 cases are surging across the country as the US heads into holiday season. Counsel patients on staying safe and keep these billing codes very close at hand.

Moderna announced safety and efficacy data from the phase 3 COVE trial that found mRNA-1273 94.5% effective in preventing infection with SARS-CoV-2.